Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2021

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Summary of Pre-funded Warrants for Common Stock Issued and Outstanding

In February 2019 and April 2020, the Company issued pre-funded warrants to purchase the Company’s common stock in underwritten public offerings at the offering price of the common stock, less the $0.0001 per share exercise price of each warrant. The warrants were recorded as a component of stockholders’ equity within additional paid-in capital and have no expiration date. Per the terms of the warrant agreements, the outstanding warrants to purchase shares of common stock may not be exercised if the holder’s ownership of the Company’s common stock would exceed 4.99% (“Maximum Ownership Percentage”), or 9.99% for certain holders. By written notice to the Company, each holder may increase or decrease the Maximum Ownership Percentage to any other percentage (not in excess of 19.99% for the majority of such warrants). The revised Maximum Ownership Percentage would be effective 61 days after the notice is received by the Company.

As of September 30, 2021, the following pre-funded warrants for common stock were issued and outstanding:

Issue Date	Expiration Date	Exercise Price		Number of Warrants Outstanding
February 8, 2019	None	$	0.0001		3,750,000
April 30, 2020	None	$	0.0001		12,860,328
Total pre-funded warrants					16,610,328

Schedule of Company’s Stock Awards Granted

The following table summarizes the Company’s stock awards granted for each of the periods indicated:

	Three Months Ended September 30,								Nine Months Ended September 30,
	2021				2020				2021				2020
	Grants		Weighted Average Grant Date Fair Value		Grants		Weighted Average Grant Date Fair Value		Grants		Weighted Average Grant Date Fair Value		Grants		Weighted Average Grant Date Fair Value
Stock options		396,200	$	4.91		409,500	$	2.45		2,557,600	$	5.05		1,853,900	$	4.61
Restricted stock units		—	$	—		228,200	$	8.13		—	$	—		228,200	$	8.13

Summary of Stock-Based Compensation Expense

Total stock-based compensation expense related to the Company’s equity incentive plans and 2016 ESPP was as follows (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2021		2020		2021		2020
Research and development	$	703	$	454	$	2,057	$	1,651
General and administrative		1,404		1,242		3,887		2,993
Total stock-based compensation expense	$	2,107	$	1,696	$	5,944	$	4,644

Schedule of Estimated Fair Value of Stock Options Granted

The following table summarizes the weighted-average Black-Scholes option pricing model assumptions used to estimate the fair value of stock options granted under the Company’s equity incentive plans, and the shares purchasable under the 2016 ESPP during the periods presented:

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2021			2020			2021			2020
Equity Incentive Plans
Expected term (in years)		6.08			6.72			5.99			6.11
Expected volatility		82	%		82	%		83	%		76	%
Risk-free interest		0.95	%		0.44	%		0.84	%		1.10	%
Dividend yield		0	%		0	%		0	%		0	%
2016 ESPP
Expected term (in years)		0.50			0.50			0.50			0.50
Expected volatility		77	%		96	%		86	%		76	%
Risk-free interest		0.08	%		0.13	%		0.08	%		0.75	%
Dividend yield		0	%		0	%		0	%		0	%